Profile of Prof Lorenzo Piemonti
At the San Raffaele Scientific Institute (Milan, Italy), I serve as Director of Diabetes Research Institute. I also serve as Head of the Beta Cell Biology Unit (Diabetes Research Institute), and Director of Human Islet Processing Facility, and coordinator of European Consortium for Islet Transplantation that has been providing Human beta Cell Products for research and clinical applications at HSR, in Italy and across state barriers in Europe since 2000. I also serve as Professor in Endocrinology at University “Vita Salute San Raffaele” of Milan and as Honorary Visiting Professor at Vrije Universiteit of Brussel. My area of expertise is mainly focused on diabetes and pancreatology. In particular I have large experience about diabetes innovative therapies, regenerative medicine and pancreatic cancer. I currently serve as section Editor of Cell Transplantation-the Regenerative Medicine Journal and as associated editor of Transplant International, as member of editorial board of Acta Dibetologia, as treasurer of the International Pancreas and Islet Transplantation Association (2019-2023, IPITA) of The Transplantation Society (TTS), as member of the National Committee for Food Safety (2018-2021, Italian Ministry of Health), as member of the steering committee The European Pancreas and Islet Transplant Registry (EPITR 2020-2025), as member of the National Board and scientific coordinator of the Italian Society of Diabetes (SID, 2020-2024) and previously (2011-2017) as member of the European Pancreas and Islet Transplantation Association (EPITA) committee of European Society for Organ Transplantation (ESOT) and Councilor of IPITA (2015-2019). Publication activity (March 2021) Lorenzo Piemonti authored a total of 235 original articles published in peer-reviewed journals surveyed in PubMed. h-index (24/03/2021): 52 Web of Science; 55 Scopus; 63 Google Scholar. Considering the period 2015-2020 Lorenzo Piemonti authored a total of 106 original articles published in peer-reviewed journals for an impact factor of 585.331 (mean impact factor: 5.522).